Non-Invasive test may predict liver transplant failure in real time
NCT ID NCT07658794
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study explores whether a non-invasive test called the vascular occlusion test (VOT), used with near-infrared spectroscopy, can predict early allograft dysfunction (EAD) in adults receiving a liver transplant. EAD is a serious complication that can lead to organ failure. Researchers will measure oxygen levels in tissues at several points during surgery and see if those readings can forecast EAD within the first week after transplant. The goal is to find a reliable way to spot trouble early, so doctors can intervene sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this test could give doctors a real-time warning during surgery, potentially improving outcomes for liver transplant patients.
What could go wrong
This is a small observational study, so results may not apply to all patients. The test might not reliably predict graft dysfunction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ippokrateio General Hospital of Thessaloniki
Thessaloniki, Thessaloniki, 54642, Greece
Contact Phone: •••-•••-•••• Email: •••••@•••••